FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Vanda Urges Makary to Intercede in Generic Dispute

[ Price : $8.95]

Vanda Pharmaceuticals urges FDA commissioner Marty Makary to reconsider a recent agency decision upholding approvals of two generi...

AdvaMed Urges FDA/CMS Alignment on Breakthrough Devices

[ Price : $8.95]

AdvaMed and other device stakeholders urge the Centers for Medicare & Medicaid Services to overhaul how it covers new device techn...

Boston Scientific Recalls Defective Stent System

[ Price : $8.95]

Boston Scientific recalls (Class 1) its Carotid Wallstent Monorail Endoprosthesis due to a manufacturing defect that created an in...

FDA 483 Shows GMP Troubles at Plant Making Eylea

[ Price : $8.95]

A new Form FDA-483 cites significant GMP issues at the plant that makes Regenerons Eylea HD (aflibercept), delaying review of two ...

FDA Clears Signos OTC Glucose Monitor

[ Price : $8.95]

FDA clears a Signos 510(k) for what the company says is the first over-the-counter glucose monitoring system designed specifically...

FDA Moves to Daily Drug Adverse Event Data

[ Price : $8.95]

FDA is now publishing drug safety data on a daily basis, a shift the agency says will give the public faster access to information...

Device Dental Bone Graft Study Guidance

[ Price : $8.95]

FDA publishes a guidance with recommendations for 510(k) animal studies for dental bone grafting material devices.

Oncology Trial Overall Survival Assessment Guide

[ Price : $8.95]

FDA publishes a draft guidance with recommendations for approaches to assessing overall survival in oncology clinical trials.

Stealth Gets Expedited Review on NDA Resubmission

[ Price : $8.95]

FDA accepts for review a Stealth BioTherapeutics NDA resubmission for elamipretide for treating Barth syndrome, with the agency ag...

Nicox Plans NDA for Glaucoma Drug

[ Price : $8.95]

Nicox plans an NDA early next year after new data from its DENALI Phase 3 study of glaucoma therapy NCX 470 showed promising resul...